Evidence map›Paper›PMID 39350737›Full record

ArticleBrain : a journal of neurology2024

Dopamine neuron dysfunction and loss in the PrknR275W mouse model of juvenile parkinsonism.

Maria Regoni, Letizia Zanetti, Martina Sevegnani, Chiara Domenicale, Stefano Magnabosco, Jyoti C Patel, Megan K Fernandes, Ryan M Feeley, Elena Monzani, Cecilia Mini and 14 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. The Juvenile Parkinson's Disease Mutation C212Y Impairs Mitochondrial Homeostasis in a Caenorhabditis elegans Model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Maria RegoniDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Letizia ZanettiDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Martina SevegnaniDulbecco Telethon Institute, Laboratory of Biology of Synapse, Center for Integrative Biology (CIBIO), University of Trento, 38123 Trento, Italy.
Chiara DomenicaleDepartment of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.
Stefano MagnaboscoDepartment of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.
Jyoti C PatelDepartment of Neurosurgery, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0003-0295-6180
Megan K FernandesDepartment of Neurosurgery, New York University Grossman School of Medicine, New York, NY 10016, USA.
Ryan M FeeleyDepartment of Neurosurgery, New York University Grossman School of Medicine, New York, NY 10016, USA.
Elena MonzaniDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Cecilia MiniDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Stefano ComaiDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0002-5686-7194
Laura CherchiDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Danilo De GregorioDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Isabella SolimanDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Fabio RutoDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Laura CrociDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Giacomo ConsalezDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Simona RodighieroDepartment of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, Milan 20139, Italy.
Andrea CiammolaIRCCS Istituto Auxologico Italiano, Department of Neurology and Laboratory of Neuroscience, 20149 Milan, Italy.
Flavia ValtortaDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.
Michele MorariDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, 35122 Padova, Italy.
Giovanni PiccoliDulbecco Telethon Institute, Laboratory of Biology of Synapse, Center for Integrative Biology (CIBIO), University of Trento, 38123 Trento, Italy.
Margaret E RiceDepartment of Neurosurgery, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0003-1793-2798
Jenny SassoneDivision of Neuroscience, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.ORCID 0000-0003-4854-1992

Funding

Benefits of Exercise on Nigrostriatal Dopamine and Motor BehaviorR01NS135884 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Margaret E Rice · 2024 to 2026
$1.7M
European UnionInvestment Partenariato Esteso PE8Ministera della Salle RF-2019-12369122Ministry of HealthMinistry of University and Research PRIN2017A9MK4RNational Recovery and Resilience PlanNextGenerationEUNIH HHS NS135884NINDS NIH HHS R01 NS135884NYU Lagone Fresco Institute for Parkinson's Disease and Movement DisordersParkinson's FoundationProject Age-ItTelethon Foundation GGP20048
6 · The paper itself

Abstract

Mutations in the PRKN gene encoding the protein parkin cause autosomal recessive juvenile parkinsonism (ARJP). Harnessing this mutation to create an early-onset Parkinson's disease mouse model would provide a unique opportunity to clarify the mechanisms involved in the neurodegenerative process and lay the groundwork for the development of neuroprotective strategies. To this end, we created a knock-in mouse carrying the homozygous PrknR275W mutation, which is the missense mutation with the highest allelic frequency in PRKN patients. We evaluated the anatomical and functional integrity of the nigrostriatal dopamine (DA) pathway, as well as motor behaviour in PrknR275W mice of both sexes. We report here that PrknR275W mice show early DA neuron dysfunction, age-dependent loss of DA neurons in the substantia nigra, decreased DA content and stimulus-evoked DA release in the striatum, and progressive motor impairment. Together, these data show that the PrknR275W mouse recapitulates key features of ARJP. Thus, these studies fill a critical need in the field by introducing a promising new Parkinson's disease model in which to study causative mechanisms of the disease and test therapeutic strategies.

Indexed as

Disease Models, AnimalDopaminergic NeuronsParkinsonian DisordersUbiquitin-Protein LigasesAnimalsCorpus StriatumDopamineFemaleGene Knock-In TechniquesMaleMiceMice, Inbred C57BLMice, TransgenicMutation, MissenseSubstantia NigraDopamineparkin proteinUbiquitin-Protein Ligasesmouse modelneurodegenerationPARKIN

Identifiers

PMID39350737
PMCPMC11733804

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.